albunorm5%, 50g/l, solution for infusion
Last Updated on eMC 16-Mar-2015 View document | Octapharma Limited Contact details
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 16-Mar-2015 and displayed until Current
Reasons for adding or updating:
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects - how to report a side effect
- Change to section 10 - Date of revision of the text
Date of revision of text on the SPC: 31-Jan-2014
Legal Category:POM
Black Triangle (CHM): NO
Free-text change information supplied by the pharmaceutical company:
$0Section 4.2: Paediatric warning movedfrom 4.4 – no change to text itselfUpdated on 26-Mar-2014 and displayed until 16-Mar-2015
Reasons for adding or updating:
- Change to section 6.3 - Shelf life
Date of revision of text on the SPC: 31-Oct-2011
Legal Category:POM
Black Triangle (CHM): NO
Free-text change information supplied by the pharmaceutical company:
shelf life 3 yearsUpdated on 09-Jan-2012 and displayed until 26-Mar-2014
Reasons for adding or updating:
- Change to section 6.1 - List of Excipients
Date of revision of text on the SPC: 01-Mar-2011
Legal Category:POM
Black Triangle (CHM): NO
Free-text change information supplied by the pharmaceutical company:
Sodium Chloride addedPotassium Removed
Updated on 20-Nov-2009 and displayed until 09-Jan-2012
Reasons for adding or updating:
- New SPC for new product
Legal Category:POM
Black Triangle (CHM): NO
Octapharma Limited
The Zenith Building, 26 Spring Gardens, Manchester, Lancashire, M2 1AB
+44 (0)161 837 3799
+44 (0)161 837 3770
0845 1300 522
+44 (0)161 837 3799
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue